Oligopotent stem cells are identified by their propensity to differentiate into a limited range of cell types, and often easier to isolate from adult tissue sources. Oligopotent stem cells tend to be found in adult tissues, such as bone marrow or the thymus, and they can differentiate into at least one, but usually no more than four, cell types. Examples of cell types that oligopotent stem cells might differentiate into include erythrocytes, leukocytes, platelets, and neurons. Though oligopotent stem cells are not as versatile as pluripotent stem cells, they still provide an important source of new cell types and can be used for various regenerative medicine purposes. One of the main benefits of oligopotent stem cell research and its applications is their usefulness in tissue regeneration and repair, as the oligopotent stem cell types often rely on in the body’s natural healing process. Oligopotent stem cells can be used to regenerate tissue and potentially restore functionality in specific organs or tissue types. Oligopotent stem cells also show promise for their potential to help treat diseases. The stem cells can be genetically modified with desired traits, and used as a treatment for conditions such as cancer and degenerative diseases. Oligopotent stem cells have already been used in clinical trials to restore vision in people living with degenerative vision loss. Finally, oligopotent stem cells have an important role in the scientific research community. First, oligopotent stem cells are a key tool in helping scientists better understand the processes of development, disease, and tissue regeneration.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States